Alpine Woods Capital Investors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-320
| Closed | -$247K | – | 242 |
|
|
2026
Q1 | $247K | Hold |
320
| – | – | 0.06% | 161 |
|
|
2025
Q4 | $247K | Buy |
+320
| New | +$217K | 0.06% | 162 |
|
|
2025
Q3 | – | Sell |
-2,055
| Closed | -$1.08M | – | 163 |
|
|
2025
Q2 | $1.08M | Sell |
2,055
-56
| -3% | -$31.3K | 0.26% | 88 |
|
|
2025
Q1 | $1.34M | Sell |
2,111
-359
| -15% | -$247K | 0.34% | 83 |
|
|
2024
Q4 | $1.76M | Sell |
2,470
-47
| -2% | -$39.4K | 0.33% | 89 |
|
|
2024
Q3 | $2.08M | Sell |
2,517
-1,652
| -40% | -$1.84M | 0.36% | 86 |
|
|
2024
Q2 | $4.38M | Buy |
4,169
+192
| +5% | +$186K | 0.68% | 52 |
|
|
2024
Q1 | $3.54M | Sell |
3,977
-3,501
| -47% | -$3.33M | 0.7% | 48 |
|
|
2023
Q4 | $6.56M | Sell |
7,478
-696
| -9% | -$573K | 0.98% | 37 |
|
|
2023
Q3 | $6.73M | Buy |
8,174
+182
| +2% | +$143K | 1.08% | 29 |
|
|
2023
Q2 | $5.74M | Buy |
7,992
+1,530
| +24% | +$1.18M | 0.9% | 43 |
|
|
2023
Q1 | $5.31M | Buy |
6,462
+2
| +0% | +$1.51K | 0.8% | 47 |
|
|
2022
Q4 | $4.66M | Sell |
6,460
-877
| -12% | -$647K | 0.68% | 54 |
|
|
2022
Q3 | $5.05M | Buy |
7,337
+500
| +7% | +$315K | 0.69% | 56 |
|
|
2022
Q2 | $4.04M | Sell |
6,837
-100
| -1% | -$65K | 0.51% | 76 |
|
|
2022
Q1 | $4.84M | Hold |
6,937
| – | – | 0.51% | 73 |
|
|
2021
Q4 | $4.38M | Buy |
6,937
+364
| +6% | +$224K | 0.43% | 82 |
|
|
2021
Q3 | $3.98M | Hold |
6,573
| – | – | 0.43% | 86 |
|
|
2021
Q2 | $3.67M | Sell |
6,573
-252
| -4% | -$128K | 0.38% | 92 |
|
|
2021
Q1 | $3.23M | Sell |
6,825
-100
| -1% | -$48.7K | 0.36% | 94 |
|
|
2020
Q4 | $3.35M | Buy |
6,925
+490
| +8% | +$265K | 0.41% | 87 |
|
|
2020
Q3 | $3.6M | Sell |
6,435
-165
| -3% | -$100K | 0.54% | 59 |
|
|
2020
Q2 | $4.12M | Sell |
6,600
-300
| -4% | -$170K | 0.79% | 32 |
|
|
2020
Q1 | $3.37M | Buy |
6,900
+2,400
| +53% | +$990K | 0.75% | 31 |
|
|
2019
Q4 | $1.69M | Hold |
4,500
| – | – | 0.32% | 75 |
|
|
2019
Q3 | $1.25M | Hold |
4,500
| – | – | 0.23% | 92 |
|
|
2019
Q2 | $1.41M | Hold |
4,500
| – | – | 0.29% | 87 |
|
|
2019
Q1 | $1.85M | Hold |
4,500
| – | – | 0.4% | 60 |
|
|
2018
Q4 | $1.68M | Sell |
4,500
-100
| -2% | -$36.6K | 0.4% | 60 |
|
|
2018
Q3 | $1.86M | Buy |
4,600
+100
| +2% | +$38.1K | 0.38% | 71 |
|
|
2018
Q2 | $1.55M | Buy |
4,500
+1,500
| +50% | +$469K | 0.34% | 76 |
|
|
2018
Q1 | $1.03M | Hold |
3,000
| – | – | 0.05% | 243 |
|
|
2017
Q4 | $1.13M | Buy |
3,000
+2,000
| +200% | +$810K | 0.06% | 237 |
|
|
2017
Q3 | $447K | Hold |
1,000
| – | – | 0.02% | 325 |
|
|
2017
Q2 | $491K | Hold |
1,000
| – | – | 0.03% | 305 |
|
|
2017
Q1 | $388K | Hold |
1,000
| – | – | 0.02% | 341 |
|
|
2016
Q4 | $367K | Sell |
1,000
-2,800
| -74% | -$1.06M | 0.02% | 342 |
|
|
2016
Q3 | $1.53M | Hold |
3,800
| – | – | 0.08% | 203 |
|
|
2016
Q2 | $1.33M | Hold |
3,800
| – | – | 0.08% | 211 |
|
|
2016
Q1 | $1.37M | Hold |
3,800
| – | – | 0.08% | 208 |
|
|
2015
Q4 | $2.06M | Hold |
3,800
| – | – | 0.11% | 175 |
|
|
2015
Q3 | $1.77M | Buy |
3,800
+1,300
| +52% | +$698K | 0.1% | 197 |
|
|
2015
Q2 | $1.27M | Hold |
2,500
| – | – | 0.07% | 234 |
|
|
2015
Q1 | $1.13M | Hold |
2,500
| – | – | 0.06% | 245 |
|
|
2014
Q4 | $1.03M | Hold |
2,500
| – | – | 0.05% | 248 |
|
|
2014
Q3 | $901K | Buy |
2,500
+1,500
| +150% | +$503K | 0.05% | 255 |
|
|
2014
Q2 | $282K | Hold |
1,000
| – | – | 0.01% | 381 |
|
|
2014
Q1 | $300K | Sell |
1,000
-1,000
| -50% | -$308K | 0.02% | 371 |
|
|
2013
Q4 | $550K | Buy |
2,000
+1,000
| +100% | +$288K | 0.03% | 271 |
|
|
2013
Q3 | $313K | Hold |
1,000
| – | – | 0.02% | 303 |
|
|
2013
Q2 | $225K | Buy |
+1,000
| New | +$233K | 0.01% | 314 |
|
Other funds holding REGN
Alpine Woods Capital Investors's REGN Position: Q2 2026 in Review
Alpine Woods Capital Investors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 320 shares — an estimated $247K sold.
Alpine Woods Capital Investors first reported a position in REGN in Q2 2013 and held it in 51 quarters. The position peaked at $6.73M in Q3 2023. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Alpine Woods Capital Investors reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Alpine Woods Capital Investors sold 320 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $247K.
- Alpine Woods Capital Investors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 51 quarters.
- Alpine Woods Capital Investors's Regeneron Pharmaceuticals position peaked at $6.73M in Q3 2023.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Alpine Woods Capital Investors's 13F filing for Q2 2026, filed 7 Aug 2026.